Jon Popke Email & Phone Number
Who is Jon Popke? Overview
A concise factual answer block for searchers comparing this professional profile.
Jon Popke is listed as Vice President, Nonclinical Drug Safety at Regeneron, based in New York, New York, United States. AeroLeads shows a matched LinkedIn profile for Jon Popke.
Jon Popke previously worked as Investor and Executive Committee Member at Mid Atlantic Bio Angels and Limited Partner at Ajim Capital. Jon Popke holds Master Of Business Administration (M.B.A.) from University Of Michigan - Stephen M. Ross School Of Business.
Email format at Regeneron
This section adds company-level context without repeating Jon Popke's masked contact details.
Review company-level records connected to Jon Popke before choosing the right outreach path.
About Jon Popke
E. Jon Popke, Ph.D., M.B.A. Experienced drug safety professional and early-stage healthcare investor; over 20 years of proven leadership in a variety of drug development settings; currently serving as Executive Director, Toxicology with Regeneron Pharmaceuticals.I received my Ph.D. from the Uniformed Services University of the Health Sciences, Bethesda, MD, and my M.B.A from the University of Michigan, Ross School of Business. Over the course of my career, I have held scientific and drug development positions of increasing responsibility with the U.S. Food and Drug Administration, Wyeth Research, MPI Research and Regeneron Pharmaceuticals. I served as Vice President of the Behavioral Toxicology Society from 2004-2005 and as President from 2005-2006. I served as an ad hoc member of the Executive Committee of the African Society for Toxicological Sciences from 2004 through 2006 and sat on the Board of Directors for the Michigan Society for Medical Research from 2008-2010. I am an active investor in early-stage health care companies and provide mentoring in support of startup entrepreneurs in Africa.Specialties: Drug Development • Scientific and Professional Leadership • Due-Diligence and Early-Stage Investing • Outsourcing and Vendor Management • Regulatory Compliance and Submission • Science, Business and Personnel Strategy
Listed skills include Toxicology, Drug Development, Cro, Pharmaceutical Industry, and 6 others.
Jon Popke's current company
Company context helps verify the profile and gives searchers a useful next step.
Jon Popke work experience
A career timeline built from the work history available for this profile.
Investor And Executive Committee Member
CurrentMid Atlantic Bio Angels (MABA), is an angel investor group focused exclusively on new and emerging life science companies.
Limited Partner
CurrentAjim Capital invests in pre-seed and seed stage companies serving under-capitalized markets across Sub-Saharan Africa.
Mentor
CurrentVenture Capital for Africa (VC4Africa) is the largest online community of entrepreneurs, mentors and investors dedicated to building game changing companies on the continent
Executive Director, Toxicology
Current- Influence overall drug development strategy from program inception to product launch
- Communicate with worldwide regulatory agencies
- Provide guidance during due diligence and business development efforts
- Partner with external experts and collaborators
- Supervise and collaborate with second-line managers and senior scientific staff
Limited Partner
CurrentTappan Hill Ventures is a capital management firm, financing companies within the health care and internet technologies domain.
Investor
LSAN provides early stage life science companies with the operational support, mentorship and financial and professional network to grow and succeed.
Director Of Toxicology
- Provided leadership to the Departments of Toxicology and Program Management with respect to science, business, and personnel strategy
- Served as consultant to VC and private equity backed pharmaceutical clients to design effective preclinical programs and prepare successful regulatory filings
- Served as primary scientific liaison to MPI Research operations in Shanghai, China and the European Union
Principal Research Scientist
- Designed and implemented preclinical safety programs to advance novel small molecules and antibody-drug conjugates toward global registration.
- Provided toxicology and safety pharmacology expertise on global project teams
- Served as standing member of the Institutional Animal Care and Use Committee (IACUC)
Scientist
Managed a cooperative Research and Development Agreement between USFDA and Astra Zeneca; Directed non-clinical research to advance the developement of a novel treatment for childhood epilepsy.
Jon Popke education
Master Of Business Administration (M.B.A.)
Certificate (Non-Degree), Private Equity And Venture Capital
Ph.D., Medical Psychology/Neuroscience
B.S., Psychology, Biology, Sociology
Frequently asked questions about Jon Popke
Quick answers generated from the profile data available on this page.
What company does Jon Popke work for?
Jon Popke works for Regeneron.
What is Jon Popke's role at Regeneron?
Jon Popke is listed as Vice President, Nonclinical Drug Safety at Regeneron.
Where is Jon Popke based?
Jon Popke is based in New York, New York, United States while working with Regeneron.
What companies has Jon Popke worked for?
Jon Popke has worked for Regeneron, Mid Atlantic Bio Angels, Ajim Capital, Vc4Africa, and Regeneron Pharmaceuticals.
How can I contact Jon Popke?
You can use AeroLeads to view verified contact signals for Jon Popke at Regeneron, including work email, phone, and LinkedIn data when available.
What schools did Jon Popke attend?
Jon Popke holds Master Of Business Administration (M.B.A.) from University Of Michigan - Stephen M. Ross School Of Business.
What skills is Jon Popke known for?
Jon Popke is listed with skills including Toxicology, Drug Development, Cro, Pharmaceutical Industry, Biotechnology, Fda, Biopharmaceuticals, and Regulatory Submissions.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial